Patient groups invest in genetic databases to speed drug development

Tens of millions of dollars are being invested by nonprofit patient groups, including the Leukemia & Lymphoma Society, the Multiple Myeloma Research Foundation and the Michael J. Fox Foundation, to create genetic databases in a push to support clinical studies and accelerate drug development. Drugmakers and scholars can analyze genetic mutations using material from these databases, which are created to gather DNA and other data from patients with hard-to-treat diseases. With the aid of these databases, patients familiar with their own genetic mutations can find information about clinical studies.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX